basel
Novartis CEO plays down prospects for Actelion bid: Blick
December 4, 2016 by elegant · Leave a Comment
Novartis Chief Executive Joe Jimenez has played down suggestions the Swiss drugmaker could bid for Swiss biotech group Actelion, which is in talks with U.S. healthcare group Johnson & Johnson about a transaction. Asked by Swiss Sunday newspaper SonntagsBlick
The rest is here:
Novartis CEO plays down prospects for Actelion bid: Blick
basel
China seeks food security with $43 billion bid for Syngenta
February 3, 2016 by publisher · Leave a Comment
By Ludwig Burger BASEL, Switzerland (Reuters) – China made its boldest overseas takeover move yet when state-owned ChemChina agreed a $43 billion bid for Swiss seeds and pesticides group Syngenta on Wednesday. The largest ever foreign purchase by a Chinese firm, announced by both companies, will accelerate a shake-up in global agrochemicals and marks a setback for U.S. firm Monsanto, which failed to buy Syngenta last year. …
See the rest here:
China seeks food security with $43 billion bid for Syngenta